Cargando…

Dual inhibition of IL-17A and IL-17F in psoriatic disease

Psoriasis and psoriatic arthritis are chronic immune-mediated disorders with involvement of interleukin (IL)-17 cytokines in their pathogenesis. IL-17A has been considered to be the most biologically active, but IL-17F is also over-expressed in skin and synovial tissues of patients with these diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iznardo, Helena, Puig, Lluís
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366125/ https://www.ncbi.nlm.nih.gov/pubmed/34408825 http://dx.doi.org/10.1177/20406223211037846

Ejemplares similares

Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies
por: Sánchez-Rodríguez, Guillermo, et al.
Publicado: (2023)

Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease
por: Iznardo, Helena, et al.
Publicado: (2021)

Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation
por: Glatt, Sophie, et al.
Publicado: (2018)

Dual Role of Th17 Cytokines, IL-17A,F, and IL-22 in Allergic Asthma
por: Schnyder, Bruno, et al.
Publicado: (2012)

IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications
por: Iznardo, Helena, et al.
Publicado: (2022)

Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis
por: Robak, Ewa, et al.
Publicado: (2019)

Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
por: van Baarsen, Lisa GM, et al.
Publicado: (2014)

The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases
por: Navarro-Compán, Victoria, et al.
Publicado: (2023)

Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms
por: Tam, Hoi Ki Joshua, et al.
Publicado: (2022)

New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function
por: Saviano, Anella, et al.
Publicado: (2023)

The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis
por: Vecellio, Matteo, et al.
Publicado: (2021)

The Th17/IL-23 Axis and Natural Immunity in Psoriatic Arthritis
por: Maeda, Shinji, et al.
Publicado: (2012)

Regulatory effects of C5a on IL-17A, IL-17F, and IL-23
por: Grailer, Jamison J., et al.
Publicado: (2013)

Expression of the T Helper 17-Associated Cytokines IL-17A and IL-17F in Asthma and COPD
por: Doe, Camille, et al.
Publicado: (2010)

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
por: Blauvelt, Andrew, et al.
Publicado: (2018)

Choosing the Appropriate Target for the Treatment of Psoriatic Arthritis: TNFα, IL-17, IL-23 or JAK Inhibitors?
por: Gialouri, Chrysoula G., et al.
Publicado: (2022)

IL17A and IL17F gene polymorphisms in patients with rheumatoid arthritis
por: Pawlik, Andrzej, et al.
Publicado: (2016)

CXCL4 is a novel inducer of human Th17 cells and correlates with IL‐17 and IL‐22 in psoriatic arthritis
por: Affandi, Alsya J., et al.
Publicado: (2018)

Clinical Significance of IL-23 Regulating IL-17A and/or IL-17F Positive Th17 Cells in Chronic Periodontitis
por: Luo, Zhenhua, et al.
Publicado: (2014)

Potential Involvement of IL-17F in Asthma
por: Ota, Kyoko, et al.
Publicado: (2014)

From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment
por: Vidal, Silvia, et al.
Publicado: (2021)

Expression of mRNA IL-17F and sIL-17F in atopic asthma patients
por: Hatta, Mochammad, et al.
Publicado: (2017)

Involvement of IL17A, IL17F and IL23R Polymorphisms in Colorectal Cancer Therapy
por: Omrane, Inés, et al.
Publicado: (2015)

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
por: McGonagle, Dennis G, et al.
Publicado: (2019)

Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells
por: Shah, Mittal, et al.
Publicado: (2020)

The Clinical Significance of Simultaneous IL-17A and IL-17F Blockade in Psoriasis Non-Responding to Anti-IL17A Therapy
por: Kokolakis, Georgios, et al.
Publicado: (2022)

IL-17A, IL-17E and IL-17F as Potential Biomarkers for the Intensity of Low-Grade Inflammation and the Risk of Cardiovascular Diseases in Obese People
por: Polak-Szczybyło, Ewelina, et al.
Publicado: (2022)

Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
por: Boutet, Marie-Astrid, et al.
Publicado: (2018)

The effects of IL-17/IL-17R inhibitors on atherosclerosis in psoriasis and psoriatic arthritis: A protocol for systematic review and meta analysis
por: Liu, Ningyuan, et al.
Publicado: (2021)

Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases
por: Qu, Ning, et al.
Publicado: (2013)

IL-17 and IL-17-producing cells in protection versus pathology
por: Mills, Kingston H. G.
Publicado: (2022)

IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis
por: Bogunia-Kubik, Katarzyna, et al.
Publicado: (2014)

Heparanase Contributes to Psoriatic Lesions Through Crosstalk with IL-17 Pathway
por: Zhu, Chengyao, et al.
Publicado: (2023)

IL-17 producing mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis
por: Noordenbos, Troy, et al.
Publicado: (2011)

The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases
por: Tabarkiewicz, Jacek, et al.
Publicado: (2015)

IL17A and IL17F genes polymorphisms are associated with histopathological changes in transplanted kidney
por: Domanski, Leszek, et al.
Publicado: (2019)

Arteriosclerosis Derived from Cutaneous Inflammation Is Ameliorated by the Deletion of IL-17A and IL-17F
por: Nakanishi, Takehisa, et al.
Publicado: (2023)

Interleukin (IL)-12 and IL-18 Synergize to Promote MAIT Cell IL-17A and IL-17F Production Independently of IL-23 Signaling
por: Cole, Suzanne, et al.
Publicado: (2020)

Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis
por: Giles, Daniel A., et al.
Publicado: (2016)

Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study
por: Joven, Beatriz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5enacti0e7m8m4pgojapjs3if3